Annexon

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Annexon and other ETFs, options, and stocks.

About ANNX

Annexon, Inc. is a clinical-stage biopharmaceutical company, which develops a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, eye and brain. It offers drugs that control or target huntington’s and alzheimer’s disease, multiple sclerosis, glaucoma, parkinson’s disease, and spinal muscular atrophy.

CEO

Douglas Love

CEODouglas Love

Employees

100

Employees100

Headquarters

Brisbane, California

HeadquartersBrisbane, California

Founded

2011

Founded2011

Employees

100

Employees100

ANNX Key Statistics

Market cap

262.77M

Market cap262.77M

Price-Earnings ratio

-2.04

Price-Earnings ratio-2.04

Dividend yield

—

Dividend yield—

Average volume

1.23M

Average volume1.23M

High today

$2.47

High today$2.47

Low today

$2.32

Low today$2.32

Open price

$2.46

Open price$2.46

Volume

1.25M

Volume1.25M

52 Week high

$7.85

52 Week high$7.85

52 Week low

$1.29

52 Week low$1.29

Analyst ratings

100%

of 8 ratings

Buy

100%

Hold

Sell

People also own

Based on the portfolios of people who own ANNX. This list is generated using Robinhood data, and it’s not a recommendation.